Wilharm, Gottfried https://orcid.org/0000-0002-1771-6799
Skiebe, Evelyn
Michalska, Andżelina
Higgins, Paul G. https://orcid.org/0000-0001-8677-9454
Weber, Kristin
Schaudinn, Christoph
Neugebauer, Christof
Görlitz, Katharina
Meimers, Gideon
Rizova, Yana
Blaschke, Ulrike
Heider, Christine
Cuny, Christiane
Drewes, Stephan
Heuser, Elisa
Jeske, Kathrin
Jacob, Jens https://orcid.org/0000-0002-5136-6606
Ulrich, Rainer G. https://orcid.org/0000-0002-5620-1528
Bocheński, Marcin https://orcid.org/0000-0002-7081-809X
Kasprzak, Mariusz
Burda, Ewa
Ciepliński, Mateusz
Kaługa, Ireneusz
Jankowiak, Łukasz https://orcid.org/0000-0002-3843-9778
Aguirre, José I.
López-García, Alejandro
Höfle, Ursula https://orcid.org/0000-0002-6868-079X
Jagiello, Zuzanna
Tobółka, Marcin
Janic, Bartosz https://orcid.org/0000-0002-2134-1555
Zieliński, Piotr https://orcid.org/0000-0002-9233-6235
Kamiński, Maciej https://orcid.org/0000-0002-4290-6308
Frisch, Johannes
Siekiera, Joachim
Wendel, Andreas F.
Brauner, Paul
Jäckel, Udo
Kaatz, Michael
Müller, Stefanie
Lübke-Becker, Antina
Wieler, Lothar H.
von Wachsmann, Johanna
Thrukonda, Lakshmipriya
Helal, Mustafa
Epping, Lennard
Wolf, Silver A. https://orcid.org/0009-0004-8164-7216
Semmler, Torsten https://orcid.org/0000-0002-2225-7267
Jerzak, Leszek
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG-FOR 2251)
EC | Erasmus+ (20/SMP/2015/16)
Article History
Received: 3 February 2024
Accepted: 13 February 2026
First Online: 10 March 2026
Competing interests
: G.W. is founder and CEO of the company HarzMicrobes GmbH, Wernigerode, Germany, dedicated to R&D on novel antibiotics. As know-how accumulated in relation to this study will be harnessed by the company, G.W. might profit from this publication in the future. The other authors declare no competing interests.